全髋关节置换术从住院仅限清单移除后改善了患者选择并扩大了优化工作
研究评估全髋关节置换术(THA)从住院仅限(IPO)清单移除前后门诊THA的患者人口学与合并症、术前优化及30天结局。全国数据库17,063例门诊THA按IPO移除前(2015-2019年,5,239例)与移除后(2020年,11,824例)分层。IPO移除后患者更年长(平均65岁 vs 62岁,P<.01),ASA 3-4级比例更高(P<.01),30天再入院(P=.57)与再手术(P=1.00)无差异,白蛋白超出阈值比例显著降低(P<.01)。
要点
- IPO移除后门诊THA患者更年长(平均65岁 vs 62岁,P<.01),ASA 3-4级比例更高(P<.01)。
- IPO移除前后30天再入院(P=.57)与再手术(P=1.00)无差异。
- IPO移除后白蛋白超出阈值比例显著降低(P<.01),血细胞比容与吸烟状态有降低趋势。
核心结论
- THA从IPO清单移除扩大了门诊关节置换的患者选择范围。
- 术前优化对减少术后并发症至关重要,本研究表明IPO移除后30天结局未恶化。
研究设计与样本
- 全国数据库17,063例门诊THA,按手术时间分层:IPO移除前(2015-2019年)5,239例,IPO移除后(2020年)11,824例。
- 比较人口学、合并症与30天结局,采用单变量与多变量分析。
- 针对白蛋白、肌酐、血细胞比容、吸烟史和体重指数等可改变风险因素建立术前优化阈值,比较各队列超出阈值患者百分比。
主要发现
- IPO移除后门诊THA患者显著更年长,平均年龄65岁(范围18-92)vs 62岁(范围18-90),P<.01。
- IPO移除后ASA 3和4级评分百分比更高(P<.01)。
- 30天再入院(P=.57)或再手术(P=1.00)无差异。
- IPO移除后白蛋白超出既定阈值百分比显著降低(P<.01),血细胞比容和吸烟状态有降低趋势。
关键数值与推荐
- 术前优化阈值针对白蛋白、肌酐、血细胞比容、吸烟史和体重指数建立,具体阈值数值原文未报告。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: On January 1, 2020, the Centers for Medicare and Medicaid Services removed total hip arthroplasty (THA) from the Inpatient-Only (IPO) list. This study evaluated patient demographics and comorbidities, preoperative optimization efforts, and 30-day outcomes of patients undergoing outpatient THA before and after IPO removal. The authors hypothesized that patients undergoing THA post-IPO removal would have improved optimization of modifiable risk factors and equivalent 30-day outcomes. METHODS: There were 17,063 outpatient THAs in a national database stratified by surgery performed before (2015 to 2019: 5,239 patients) and after IPO (2020: 11,824 patients) removal. Demographics, comorbidities, and 30-day outcomes were compared with univariable and multivariable analyses. Preoperative optimization thresholds were established for the following modifiable risk factors: albumin, creatinine, hematocrit, smoking history, and body mass index. The percentage of patients who fell outside the thresholds in each cohort were compared. RESULTS: Patients undergoing outpatient THA post-IPO removal were significantly older; mean age 65 years (range, 18 to 92) versus 62 (range, 18 to 90) years (P < .01), with a higher percentage of American Society of Anesthesiologists scores 3 and 4 (P < .01). There was no difference in 30-day readmissions (P = .57) or reoperations (P = 1.00). A significantly lower percentage of patients fell outside the established threshold for albumin (P < .01) post-IPO removal, and trended towards lower percentages for hematocrit and smoking status. CONCLUSION: The removal of THA from the IPO list expanded patient selection for outpatient arthroplasty. Preoperative optimization is critical to minimize postoperative complications, and the current study demonstrates that 30-day outcomes have not worsened post-IPO removal.
引用
- Cochrane NH, Kim BI, Seyler TM, et al. The Removal of Total Hip Arthroplasty From the Inpatient-Only List has Improved Patient Selection and Expanded Optimization Efforts. J Arthroplasty. 2023. PMID: 36898484. doi:10.1016/j.arth.2023.03.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。